Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
-
Pursue Status Neutral Approach: Program Letter
Program letter encourages public health partners and grant recipients to implement status neutral approaches to HIV care and prevention.News Article updated on 01/18/2023 -
Ryan White Conference Database Expands
A searchable database is now available to access slides and videos from HRSA Ryan White Conferences stretching back to 2020.Blog updated 03/28/2024
-
Write about Your HIV Intervention with Confidence
Not sure how to tackle the task of writing about your intervention? IHIP can help.News Article updated on 01/27/2023 -
FY24 RWHAP Part A Program Terms Report Manual
Instructions on how RWHAP Part A recipients on the RWHAP Part A PTR.Resource updated 04/03/2024
-
HIV Clinical Pharmacist Services
The HIV Clinical Pharmacist Services intervention shortens the time between referral to and engagement in care by allowing newly referred clients to see pharmacists in addition to other clinical providers for their initial appointment. This intervention is supported by findings from a retrospective cohort study that took place from 2013 to 2017 at a RWHAP-funded clinic. In addition to significantly decreasing the time between referral and initial visit, clients who saw a pharmacist also experienced shortened time to antiretroviral therapy initiation and viral suppression compared to those who only saw non-pharmacist providers.Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
-
RWHAP Part D: Introduction to the Part D Basic Training Program
Training and education on programmatic and legislative requirements for new and continuing RWHAP Part D program recipients.Resource (Conference Presentation) updated 09/14/2023
-
How to Conduct Remote Subrecipient Site Visits
Best practices and tools for conducting effective remote subrecipient monitoring. Presentation from the HRSA HIV/AIDS Bureau Division of State HIV/AIDS Programs (DSHAP) Business Day Meeting at the 2022 RWC.Resource (Conference Presentation) updated 09/14/2023
-
Succession Planning
Strategies and considerations in successful succession planning. Presentation from the HRSA HIV/AIDS Bureau Division of State HIV/AIDS Programs (DSHAP) Business Day Meeting at the 2022 RWC.Resource (Conference Presentation) updated 09/14/2023
-
Simplifying Salvage Antiretroviral Regimens in Treatment-Experienced PLWH
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
-
HIV Clinic Staff and Community Perspectives on Long-Acting Injectable ART in New York City
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
-
Addressing and Identifying Food Insecurity in a Southeastern Ryan White Clinic
Description of an intervention to address food insecurity in a RWHAP-eligible population in a Southeastern U.S. clinic, with plans to examine the association with viral suppression and retention in care.
Resource (Conference Presentation) updated 09/14/2023
-
Assessing Medication Access Barriers in Patients Living with HIV
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023
-
Maintaining Open Communication in a City without Power: A Communication Model Following Hurricane Ida
Following Hurricane Ida in New Orleans, Tulane ID providers utilized an innovative communication model to contact patients using a Google Voice number to act as the clinic call back number. Using this model, 88 out of 132 patients were successfully reached, with 36 percent of those that answered requiring urgent refills.
Resource (Conference Presentation) updated 09/14/2023
-
Listening Session on Policy Clarification Notice 16-02 Ryan White HIV/AIDS Program Services: Eligible Individuals and Allowable Uses of Funds
Listening Session on how Policy Clarification Notice 16-02 and how the HRSA HAB RWHAP service categories and allowable uses of funds can be refreshed to best reflect new and emerging needs, science, and service delivery models.
Resource (Conference Presentation) updated 09/14/2023
-
Community Co-Creation: Engaging Traditional and Nontraditional Partners in a National Viral Suppression Campaign
HHS process for development of the “I Am a Work of ART” viral suppression campaign, in collaboration with community partners. of the National HIV/AIDS Strategy.
Resource (Conference Presentation) updated 09/14/2023
-
National HIV Curriculum 3rd Edition Launched
After extensive reviews and updates, the National HIV Curriculum 3rd Edition launched on September 1 to start a new 3-year CE accreditation period.News Article updated on 09/27/2023 -
Non-Competing Continuation RWHAP Part B/ADAP (X07): FY24 NCC Progress Report Submission
Instructions and resources for completing and submitting the FY 2024 Ryan White HIV/AIDS Program (RWHAP) Part B Non-Competing Continuation Progress Report.Resource updated 10/10/2023
-
RWHAP Part C Allocations Report Manual
Instructions on how all Ryan White HIV/AIDS Program (RWHAP) Part C recipients can access, complete, and submit the RWHAP Part C Allocations Report.
Resource updated 06/27/2024
-
Long-Acting Injectables for HIV Antiretroviral Therapy
Guide for EHE jurisdictions on what they can do to enhance implementation of long-acting injectable antiretroviral therapy.Resource updated 04/12/2024